Even more, considering that PD-L1 in exosomes has also been related to tumor growth and progression, exosomal PD-L1 is not only a prime candidate to be used as a predictive biomarker of therapy response, but it may aid in the diagnosis and staging of cancer [14, 62]. Here, CD274 is linked to neoplasm.